Bionano Genomics, Inc. (BNGO)

Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.79	17.95	5.09	24.57	38.45	17.31
Short-Term Investments	3.16	48.82	108.1	226.04	-	-
Cash & Short-Term Investments	11.95	66.77	113.19	250.61	38.45	17.31
Cash Growth	-81.20%	-41.01%	-54.84%	551.80%	122.10%	4.77%
Accounts Receivable	5.32	9.32	7.02	4.93	2.78	6.33
Other Receivables	-	0.34	0.47	-	-	-
Receivables	5.32	9.66	7.5	4.93	2.78	6.33
Inventory	14.32	22.89	29.76	12.39	3.32	3.44
Prepaid Expenses	4.39	1.1	1.39	4.48	0.64	0.3
Other Current Assets	11	39.69	5.47	-	1.61	0.87
Total Current Assets	46.98	140.12	157.3	272.41	46.79	28.26
Property, Plant & Equipment	26.18	32.48	28.96	20.94	4.91	1.95
Goodwill	-	-	77.29	56.16	7.17	-
Other Intangible Assets	11.05	33.97	41.14	26.84	1.48	-
Other Long-Term Assets	3.16	7.83	2.81	0.75	0.1	-
Total Assets	87.36	214.4	307.5	377.1	60.45	30.21
Accounts Payable	8.7	10.38	12.53	10.77	2.93	2.7
Accrued Expenses	4.6	6.58	9.22	6.94	4.36	2.5
Short-Term Debt	14.95	69.8	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	20.08
Current Portion of Leases	2.22	2.44	2.55	1.77	-	-
Current Income Taxes Payable	1.01	1.1	0.83	0.68	0.56	0.27
Current Unearned Revenue	1.2	0.78	0.87	0.68	0.42	0.36
Other Current Liabilities	0.27	8.94	9.89	1	0.68	0.46
Total Current Liabilities	32.95	100.03	35.88	21.84	8.95	26.37
Long-Term Debt	-	-	-	-	16.33	-
Long-Term Leases	5.28	7.18	9.12	8.93	-	-
Long-Term Unearned Revenue	0.26	0.15	0.13	0.15	0.1	0.18
Other Long-Term Liabilities	-	10.89	12.97	9.07	-	0.04
Total Liabilities	38.49	118.25	58.1	39.98	25.37	26.59
Common Stock	0.01	0.01	0	0.03	0.02	0
Additional Paid-In Capital	720.43	677.34	599.23	553.75	178.75	106.19
Retained Earnings	-673.1	-581.21	-348.72	-216.12	-143.68	-102.58
Comprehensive Income & Other	1.53	0.02	-1.12	-0.54	-	-
Total Common Equity	48.87	96.16	249.4	337.12	35.08	3.61
Shareholders' Equity	48.87	96.16	249.4	337.12	35.08	3.61
Total Liabilities & Equity	87.36	214.4	307.5	377.1	60.45	30.21
Total Debt	22.45	79.41	11.67	10.7	16.33	20.08
Net Cash (Debt)	-10.5	-12.64	101.52	239.92	22.12	-2.77
Net Cash Growth	-	-	-57.69%	984.42%	-	-
Net Cash Per Share	-0.17	-0.37	3.51	8.67	2.12	-1.85
Filing Date Shares Outstanding	101.99	54.69	30.62	28.96	27.87	3.78
Total Common Shares Outstanding	88.47	45.75	29.72	28.96	19	3.43
Working Capital	14.03	40.09	121.41	250.57	37.84	1.89
Book Value Per Share	0.55	2.10	8.39	11.64	1.85	1.05
Tangible Book Value	37.82	62.18	130.97	254.12	26.43	3.61
Tangible Book Value Per Share	0.43	1.36	4.41	8.77	1.39	1.05
Machinery	-	38.68	27.11	16.72	10.48	6.35
Leasehold Improvements	-	3.75	4	2.67	1.89	1.88

Source: S&P Capital IQ. Standard template. Financial Sources.